Grant of Options

RNS Number : 8911P

Rosslyn Data Technologies PLC

15 June 2020

 

15 June 2020

Rosslyn Data Technologies plc

("Rosslyn" the "Group")

Grant of Options

Rosslyn Data Technologies plc (AIM: RDT), the provider of a leading cloud-based enterprise data analytics platform , announces that the Company has granted a total of 9,171,425 options to subscribe for new ordinary shares in the Company under the Rosslyn 2014 Share Option Program to various employees of the Company (the "Options").

A total of 7,266,664 of the Options are split into three equal tranches and each tranche shall vest evenly over a three-year period, subject to performance criteria having been met during the financial year ending 30 April 2021, provided that the Option holder remains an employee or director of the Group. A further 1,904,761 options will vest immediately.

Each employee's options will lapse immediately on that employee's resignation. The Options are exercisable at 5.25p pence and will expire on 11 June 2030.

The following options have been granted to Directors and PDMRs:

	Director	Number of options granted	Total number of options
	Roger Bullen	3,047,619	9,594,178
	Hugh Cox	1,238,095	3,015,873
	Ash Mehta	3,142,856	4,522,166

Rosslyn Data Technologies plc	Roger Bullen, Chief Executive Officer	[phone] [phone]
	Ash Mehta, Chief Financial Officer	[phone] [phone]
Cenkos Securities, Nominated Adviser, Broker	Stephen Keys/Giles Balleny	[phone]

Notes to Editors

Rosslyn Data Technologies plc, (AIM: RDT) is a leading provider of a cloud-based big-data analytics platform. The company provides analytical services by combining four key technologies: bulk data extraction; cleansing; enrichment; and visualisation, through a single cloud platform enabling users with detailed data to make more informed decisions. Rosslyn's RAPid platform is the Group's primary product available to its multinational customers.

Further information can also be found on the Company's website at:  www.rosslyndatatech.com

 

END

 

 

IOEFFFFLRRISLII